Enterprise Ireland

Galway Biomedical develops and manufactures medical devices.

NUA Surgical is an innovative start-up located at the Innovation Hub in Galway, Ireland, focused on enhancing women's health through advanced medical devices. The company has developed a patented surgical retractor specifically designed to improve the safety and efficiency of cesarean deliveries. By concentrating on research and development, NUA Surgical aims to provide obstetricians with tools that facilitate superior surgical outcomes, ultimately making C-sections safer for patients.

Ovagen is a biotechnology company specializing in the large-scale production of germ-free chicken eggs and birds, primarily for the pharmaceutical industry. The company's innovative process utilizes a transgenic chicken platform to produce recombinant proteins to Good Manufacturing Practice (GMP) standards. This technology provides pharmaceutical companies with a biosecure and flexible biomanufacturing solution for developing vaccines and therapeutic proteins. In addition to its core offerings, Ovagen also provides Contract Research Services and has expertise in specific poultry and rodent research technologies, as well as in SPF poultry and rodent housing and husbandry.

SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life. About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation

Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.

NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside.

BeyondBMI operates a health technology platform focused on weight management. The company offers personalized support and motivation through a range of services, including access to doctor-prescribed weight loss medications, nutritional therapy, and one-on-one coaching. By providing non-judgmental medical expertise and the latest therapeutic options, BeyondBMI aims to transform the lives of individuals affected by obesity, facilitating their journey towards healthier living.

pHetalSafe is a fetal sensor designed to detect fetal hypoxia a damaging condition which can result in long-term brain damage for newborns.

NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside.

seamlessCARE is a Digital Health Start-up. It can help people with communication difficulties due to autism, stroke, dementia, intellectual disability, and a wide range of other conditions

Gasgon Medical is a medical device company focused on enhancing intravenous (IV) infusion processes to improve patient outcomes and support healthcare professionals. The company develops innovative devices aimed at optimizing clinical efficiency and reducing risks associated with IV administration, such as Vascular Air Embolism. By addressing the challenges faced by clinicians in delivering IV medicine, Gasgon Medical seeks to foster a future where all IV treatments can be administered with confidence, ultimately aiming to elevate the standard of care in healthcare settings.

SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life. About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation

FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing and marketing a connected-health technology known as Tight Alright, which is designed to measure and monitor sub-bandage pressure during compression therapy for venous leg ulcers (VLUs). This technology addresses a critical challenge in VLU treatment, as improper pressure application can lead to ineffective or dangerous outcomes. By providing live readings and recorded data, FeelTect's device allows both patients and healthcare providers to ensure that compression therapy is applied safely and effectively, ultimately facilitating optimal, individualized treatment regimens. The innovation not only enhances patient care but also aims to reduce the economic burden associated with VLU management.

HealthBeacon is a connected health care device designed to drive treatment adherence for patients on self-injectable medications. It observes patient compliance, identifies patient behavior, and subsequently engages the patient to achieve higher medication adherence for patients on home injectable medication. HealthBeacon also alerts patients when they need to take their medication and sends them a text when they forget.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.

THEYA Healthcare is a medical device company that specializes in designing and manufacturing innovative post-surgery garments, particularly for women recovering from breast cancer surgeries. Founded by Ciara Donlon in 2015, the company emerged from a recognized need for comfortable and feminine underwear that catered to the specific requirements of women during their recovery. Theya Healthcare's flagship product line features bras made from a unique bamboo blend fabric, which is proven to be antibacterial, highly absorbent, and effective at wicking moisture away from the skin. Clinical trials conducted in Dublin demonstrated that patients wearing Theya Healthcare bras experienced significant improvements in body image and health status, while also reporting reduced pain and discomfort compared to competing products. Since its inception, Theya Healthcare has garnered numerous accolades for its contributions to women's health, including the Cartier Women's Initiative Award and recognition in the EY Entrepreneur of the Year program.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation

HealthBeacon is a connected health care device designed to drive treatment adherence for patients on self-injectable medications. It observes patient compliance, identifies patient behavior, and subsequently engages the patient to achieve higher medication adherence for patients on home injectable medication. HealthBeacon also alerts patients when they need to take their medication and sends them a text when they forget.

Kinesis Health Technologies is an award-winning digital health company offering solutions for assessment of physical function as well as prevention and assessment of falls risk in older adults. Our medical device technologies are patent protected and based on 12 years of research conducted in Ireland. Our team has extensive business, marketing, and technical experience. Kinesis Health Technologies was founded in 2013 and are based in Dublin, Ireland.

Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Incereb is an Irish medical device company based in Dublin, specializing in the neonatal intensive care unit (NICU) market. Founded in May 2011, the company focuses on designing and developing disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products tailored for term and preterm infants. These innovative products require minimal training for medical professionals, significantly simplifying the setup process for monitoring neonates. Incereb's devices are compatible with various EEG and CFM recording equipment, enhancing their versatility in clinical settings. The company is committed to investing in research and development to expand its product offerings and has established strategic partnerships with leading Irish universities and hospitals. These collaborations aim to harness local scientific expertise, facilitating the quick commercialization of new devices and supporting the company’s growth trajectory.

The Hamstring Solo is an exercise aid for carrying out hamstring eccentric and concentric exercises.

Connexicon Medical specializes manufacturing tissue adhesives and sealants for topical and internal applications.

Rockfield Medical Devices is a small to medium-sized enterprise focused on transforming the enteral feeding market through innovative design and user-centered solutions. Founded by a team of experts in the medical device industry and research, the company aims to enhance the mobility and quality of life for individuals relying on tube feeding. Rockfield's platform introduces a lightweight and discreet mobile feeding system that significantly improves user experience while reducing technical support and maintenance costs for sales partners. Through its commitment to innovation and usability, Rockfield strives to deliver exemplary satisfaction to end users in the enteral feeding community.

Firmwave provides design, research, and development services for smart connected IoT devices and wearable devices in various vertical markets such as industrial, energy, medical/healthcare, and smart buildings.

Oculer has been specifically developed and optimised for the detection of thermoduric bacteria in milk and associated dairy products. The system utilises a number of patented technologies and processes which, have facilitated the provision of a rapid, high throughput system for the accurate detection of thermodurics, and is developing a suite of products that will enable in-process and finished product testing for smaller sample sizes.

CMC Hygea Ltd. is a manufacturer of Class 1 medical devices focused on developing hygienic healthcare products aimed at preventing infectious diseases. The company offers a range of infection control solutions, including a patient bathing system designed to reduce the spread of bacteria that can lead to healthcare-associated infections (HAIs). Additionally, CMC Hygea provides effective methods for cleaning and treating leg ulcers, contributing to improved infection control and prevention within the global healthcare system.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

PolyDev is a limited company set up to bring specialist innovation to the cosmetic contact lens market. It has a core competence in biomedical inks and printing, and has used this expertise to bring the TORIColors lens to market. PolyDev is the manufacturer of TORIColors brand of cosmetic contact lens. They are on sale in the US currently and will be released to other countries as regulatory compliance is achieved.

Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that develop between the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.

Kinesis Health Technologies is an award-winning digital health company offering solutions for assessment of physical function as well as prevention and assessment of falls risk in older adults. Our medical device technologies are patent protected and based on 12 years of research conducted in Ireland. Our team has extensive business, marketing, and technical experience. Kinesis Health Technologies was founded in 2013 and are based in Dublin, Ireland.

THEYA Healthcare is a medical device company that specializes in designing and manufacturing innovative post-surgery garments, particularly for women recovering from breast cancer surgeries. Founded by Ciara Donlon in 2015, the company emerged from a recognized need for comfortable and feminine underwear that catered to the specific requirements of women during their recovery. Theya Healthcare's flagship product line features bras made from a unique bamboo blend fabric, which is proven to be antibacterial, highly absorbent, and effective at wicking moisture away from the skin. Clinical trials conducted in Dublin demonstrated that patients wearing Theya Healthcare bras experienced significant improvements in body image and health status, while also reporting reduced pain and discomfort compared to competing products. Since its inception, Theya Healthcare has garnered numerous accolades for its contributions to women's health, including the Cartier Women's Initiative Award and recognition in the EY Entrepreneur of the Year program.

Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.

Tapa Healthcare is an Irish Medical Technology start-up supported by Enterprise Ireland, armed with 18 years of clinical research, and the mission of providing proactive patient-centric care.

SiriusXT Limited, based in Dublin, Ireland, specializes in the development and manufacturing of a soft x-ray microscope known as the SXT system. Founded in 2015, the company primarily serves researchers in disease research and drug discovery. The microscope employs a vacuum-based laser-produced plasma light source, enabling high-resolution imaging of the 3D internal structure of cells in their native, fully hydrated state. This technology is akin to a CT scan for cells, allowing for detailed visualization without the need for stains or contrast agents. The SXT system is particularly beneficial for disease researchers, pharmaceutical companies, and biotechnologists, as it facilitates the understanding of disease pathways, protein-drug interactions, and bio-engineering processes. As the first high-throughput, bench-top soft x-ray microscope, SiriusXT's system can produce full cell 3D tomographs in a matter of minutes, significantly advancing imaging capabilities in scientific research.

AventaMed is a start-up medical device company focused on improving patient care and reducing healthcare costs. The company is a spin-out from the 'MEDIC' research centre within the Cork Institute of Technology and has been founded upon technology developed from 4 years of product development.

Contego Sports Ltd was founded in Galway, Republic of Ireland by Mark and Dr Sandra Ganly, a couple who have combined their vast expertise in two different fields to develop this next generation head guard. Mark Ganly has over ten years’ experience in sports equipment design and manufacturing, while Dr Sandra Ganly has a PhD and extensive experience in the field of biomedical engineering and medical device innovation:

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Qualio, Inc. specializes in cloud-based quality management software tailored for the life sciences sector, including medical device manufacturers, pharmaceutical and biotech companies, and contract service providers. Founded in 2012 and headquartered in San Francisco, with an office in Dublin, Qualio's platform facilitates compliance with GxP, FDA, and ISO standards, helping organizations streamline premarket activities, registration, and regulatory requirements. The software offers comprehensive features for document control, training, risk management, complaint handling, and internal audits, among others. By uniting teams and processes within a single platform, Qualio enables over 500 companies across 80 countries to enhance efficiency, reduce risks, and foster a culture of quality, ultimately supporting faster market entry and business growth.

Thalman Health is focused on transforming thermometry through innovative core sensor technology that enables continuous clinical-grade monitoring of vital signs, particularly body temperature. The company develops wireless, wearable devices that integrate with a sensor-enabled platform to provide 24-hour monitoring of patients. These devices allow healthcare providers to track core body temperature in real time and receive alerts if a patient's condition begins to decline, facilitating early detection of fever and other health issues. By enhancing the ability to monitor vital signs continuously, Thalman Health aims to improve patient care and outcomes in clinical settings.

PMD Solutions is focused on transforming respiratory monitoring through the development of an innovative, body-worn wireless sensor. This device continuously and discreetly tracks patients' respiratory rates from the time of administration until discharge. By directly measuring the mechanical movements of the chest and abdomen during breathing, the technology allows healthcare professionals to accurately assess and identify any deterioration in patients' conditions. This approach aims to enhance respiratory outcomes and improve overall patient care.

Adama Innovations Ltd. is a company based in Dublin, Ireland, that specializes in developing nanotechnology solutions for advanced manufacturing. Founded in 2010 as a spin-out from CRANN, the nanotechnology institute at Trinity College Dublin, the company focuses on creating high-resolution patterns on ultra-hard materials. Its flagship product is a diamond-based nano-scale probe designed for atomic force microscopy (AFM), which allows for precise imaging, measurement, and manipulation at the nanoscale. These probes have diverse applications, including general topography, electrical analysis, and sidewall characterization. Additionally, Adama Innovations produces diamond sharp cones and flare-shaped probes for various metrology applications. The company’s technology also supports the manufacturing of medical devices by enhancing the capabilities of injection molds and forming dies, while contributing to labeling and anti-counterfeiting solutions.

Embo Medical is based in National University of Ireland. Embo is developing the first true one-shot (one device per vessel) vascular embolisation device. The product is aimed at the peripheral vascular embolization market, a market where physicians perform about 180,000 procedures per year worldwide.

PMD Solutions is focused on transforming respiratory monitoring through the development of an innovative, body-worn wireless sensor. This device continuously and discreetly tracks patients' respiratory rates from the time of administration until discharge. By directly measuring the mechanical movements of the chest and abdomen during breathing, the technology allows healthcare professionals to accurately assess and identify any deterioration in patients' conditions. This approach aims to enhance respiratory outcomes and improve overall patient care.

Biosensia Ltd. is a company based in Dublin, Ireland, that specializes in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic platform designed to provide both quantitative and qualitative laboratory test results. RapiPlex consists of a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. This advancement supports near-patient care without sacrificing analytical performance. The platform is versatile, capable of analyzing various biological samples such as whole blood, plasma, serum, urine, saliva, and milk. Biosensia also focuses on applications in theranostics, veterinary testing, and food safety. The company was founded in 2000 and was previously known as NanoComms Ltd. Biosensia operates as a subsidiary of Kypha Inc. since 2018.

Neuromod Devices Limited is a Dublin-based medical device company founded in 2010, focusing on the research and development of neuromodulation treatments for chronic tinnitus, a condition affecting approximately 10% of adults. The company has developed a patented bi-modal neuromodulation technology, exemplified by its product, the mutebutton. This device aims to promote positive therapeutic changes in the nervous system, offering a targeted approach to alleviate the suffering of patients living with chronic tinnitus. Neuromod is dedicated to providing innovative treatments that empower patients to manage their conditions while integrating seamlessly into their modern lifestyles.

Radisens Diagnostics is focused on developing a digital diagnostic device designed for point-of-care testing in general practice clinics, emergency rooms, and outpatient departments. Recognizing the limitations of current tests, which often assess individual analytes and lack integration with health records, the company aims to provide a comprehensive solution that addresses the growing need for efficient diagnostics amidst rising chronic diseases such as diabetes, heart disease, and hypertension. Their platform offers multiplexed test panels that integrate immunochemistry, clinical chemistry, and hematology assays, requiring only a drop of blood to deliver instant results. Initially targeting chronic disease panels related to diabetes, heart disease, hypertension, and chronic kidney disease, Radisens Diagnostics plans to expand its offerings to include cell counting and oncology tests. This innovative approach seeks to enhance diagnostic capabilities in healthcare settings, ultimately reducing costs and improving patient outcomes by facilitating timely and informed medical decisions.

NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device that simultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.

NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device that simultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.

Eblana Photonics Ltd. designs and manufactures laser diode products for various industries, including space, medical, sensor, and fiber-optic communications. Established in 2000 and based in Dun Laoghaire, Ireland, Eblana also has offices in several countries, including France, Germany, the United States, Japan, China, and Taiwan. The company emerged from advanced research collaborations with leading Irish universities, such as Trinity College Dublin and the National Microelectronics Research Centre. Founded by Dr. James O’Gorman and Prof. John Hegarty, who have extensive backgrounds in laser research, Eblana aims to commercialize scalable laser manufacturing technology. This technology enables the production of high-performance, single-wavelength lasers at reduced costs, serving diverse mass market applications in broadband, access, and enterprise markets, as well as optical sensing and metrology. Additionally, Eblana offers research and development services on a contract basis.